[1. S. Levy and S. J. Azoulay, Story about the origin of quinquina and quinidine, J. Cardiovasc. Electrophysiol.5 (1994) 635–636; DOI: 10.1111/j.1540-8167.1994.tb01304.x.10.1111/j.1540-8167.1994.tb01304.x]Search in Google Scholar
[2. K. F. Wenckcbach, Cinchona derivatives in the treatment of heart disorders, JAMA81 (1923) 472–474; DOI: 10.1001/jama.1923.02650060042012.10.1001/jama.1923.02650060042012]Search in Google Scholar
[3. A. B. Adnan, A. E. Ola, A. Elsayed and J. I. Young Park, Tetrazolo[1,5-a]quinoline as a potential promising new scaffold for the synthesis of novel anti-inflammatory and antibacterial agents, Eur. J. Med. Chem. 39 (2004) 249–255; DOI: 10.1016/j.ejmech.2003.12.-005.]Search in Google Scholar
[4. E. Sumesh, V. A. Airody and N. S. Suchetha, Synthesis and antimicrobial activities of novel quinoline derivatives carrying 1, 2, 4-triazole moiety, Eur. J. Med. Chem. 44 (11) (2009) 4637–4647; DOI: 10.1016/j.ejmech.2009.06.031.10.1016/j.ejmech.2009.06.031]Search in Google Scholar
[5. M. Zhongze, H. Yoshio, N. Taro and C. Yingjie, Novel quinazoline-quinoline alkaloids with cytotoxic and DNA topoisomerase II inhibitory activities, Bioorg. Med. Chem. Lett.14 (2004) 1193–1196; DOI: 10.1016/j.bmcl.2003.12.048.10.1016/j.bmcl.2003.12.048]Search in Google Scholar
[6. E. Sumesh, V. A. Airody and R. A. Kumar, New 1,3-oxazolo [4,5-c] quinoline derivatives: Synthesis and evaluation of antibacterial and antituberculosis properties, Eur. J. Med. Chem.45 (2010) 957–966; DOI: 10.1016/j.ejmech.2009.11.036.10.1016/j.ejmech.2009.11.036]Search in Google Scholar
[7. M. Hranjec, M. Kralj, I. Piantanida, M. Sedic, L. Šuman, K. Pavelic and G. Karminski-Zamola, Novel cyano- and amidino-substituted derivatives of styryl-2-benzimidazoles and benzimidazo[1,2-a] quinolines. Synthesis, photochemical synthesis, DNA binding, and antitumor evaluation, part 3, J. Med. Chem. 50 (2007) 5696–5711; DOI: 10.1021/jm070876h.10.1021/jm070876h]Search in Google Scholar
[8. S. Madapa, Z. Tusi and S. Batra, Advances in the syntheses of quinoline and quinoline-annulated ring systems, Curr. Org. Chem.12 (2008) 1116–1183; DOI: 10.2174/138527208785740300.10.2174/138527208785740300]Search in Google Scholar
[9. P. Muthumani, S. Venkataraman, R. Meera, N. Govind, N. Chidambaranathan P. Devi and B. Kameswari, Synthesis and biological screening of some novel quinoline derivatives, Pharma Chem. 2 (2010) 385–396.]Search in Google Scholar
[10. J. Borran, A. Scozzafava, L. Menabuoni, F. Mincione, F. Briganti, G. Mincione and C. T. Supuran, Carbonic anhydrase inhibitors: synthesis of water-soluble, topically effective intraocular pressure lowering aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties: is the tail more important than the ring?, Bioorg. Med. Chem.7 (1999) 2397–2406; DOI: 10.1016/S0968-0896(99)00190-X.10.1016/S0968-0896(99)00190-X]Search in Google Scholar
[11. V. K. Aqrawal, S. Bano, C. T. Supuran and P. V. Khadikar, QSAR study on carbonic anhydrase inhibitors: aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties, with topical activity as antiglaucoma agents, Eur. J. Med. Chem. 39 (2004) 593–600; DOI: 10.1016/j.ejmech.2004.03.002.10.1016/j.ejmech.2004.03.00215236839]Search in Google Scholar
[12. W. Peczynska-Czoch, F. Pognan, L. Kaczmarek and J. Boratynski, Synthesis and structure-activity relationship of methyl-substituted indolo [2,3-b]quinolines: Novel cytotoxic, DNA topoisomerase II inhibitors, J. Med. Chem. 37 (1994) 3503–3510; DOI: 10.1021/jm-00047a008.]Search in Google Scholar
[13. M. S. Al-Dosari, M. M. Ghorab, M. S. Alsaid, Y. M. Nissan and A. B. Ahmed, Synthesis and anticancer activity of some novel trifluoromethylquinolines carrying a biologically active benzenesulfonamide moiety, Eur. J. Med. Chem. 69 (2013) 373–383; DOI: 10.1016/j.ejmech.-2013.08.048.]Search in Google Scholar
[14. M. M. Ghorab, Z. H. Ismail, M. Abdalla and A. A. Radwan, Synthesis, antimicrobial evaluation and molecular modelling of novel sulfonamides carrying a biologically active quinazoline nucleus, Arch. Pharm. Res. 36 (2013) 660–670; DOI: 10.1007/s12272-013-00946.]Search in Google Scholar
[15. M. M. Ghorab, Z. H. Ismail, A. A. Radwan and M. Abdalla, Synthesis and pharmacophore modeling of novel quinazolines bearing a biologically active sulfonamide moiety, Acta. Pharm.63 (2013) 1–18; DOI: 10.2478/acph-2013-0006.10.2478/acph-2013-000623482309]Search in Google Scholar
[16. M. S. Al-Dosari, M. M. Ghorab, M. S. Alsaid and Y. M. Nissan, Discovering some novel 7-chloroquinolines carrying a biologically active benzenesulfonamide moiety as a new class of anticancer agents, Chem. Pharm. Bull. 61 (2013) 50–58; DOI: 10.10-02/chin.201328146.10.1248/cpb.c12-0081223302586]Search in Google Scholar
[17. D. A. Abou El Ella, M. M. Ghorab, H. I. Heiba and A. M. Soliman, Synthesis of some new thiazolopyrane and thiazolopyranopyrimidine derivatives bearing a sulfonamide moiety for evaluation as anticancer and radiosensitizing agents, Med. Chem. Res.21 (2012) 2395–2407; DOI: 10.1007/s00044-011-9751-9.10.1007/s00044-011-9751-9]Search in Google Scholar
[18. M. M. Ghorab, M. S. Alsaid and Y. M. Nissan, Dapson in heterocyclic chemistry, part VI: Synthesis and molecular docking of some novel sulfonebiscompounds of expected anticancer activity, Arzneimittel-forsch.62 (2012) 497–507; DOI: 10.1055/s-0032-1323660.10.1055/s-0032-132366023023519]Search in Google Scholar
[19. M. M. Ghorab, M. A. Shaaban, H. M. Refaat, H. I. Heiba and S. S. Ibrahim, Anticancer and radio-sensitizing evaluation of some new pyranothiazole-Schiff bases bearing the biologically active sulfonamide moiety, Eur. J. Med. Chem. 53 (2012) 403–407; DOI: 10.1016/j.-ejmech.2012.04.009.]Search in Google Scholar
[20. M. M. Ghorab, F. A. Ragab, H. I. Heiba, Y. M. Nissan and W. M. Ghorab, Novel brominated quinoline and pyrimidoquinoline derivatives as potential cytotoxic agents with synergistic effects of gamma-radiation, Arch. Pharm. Res. 8 (2012) 1335–1346; DOI: 10.1007/s-12272-012-0803-6.]Search in Google Scholar
[21. M. M. Ghorab, M. S. Alsaid and Y. M. Nissan, Dapson in heterocyclic chemistry, part V: Synthesis, molecular docking and anticancer activity of some novel sulfonylbis-compounds carrying biologically active dihydropyridine, dihydroisoquinoline, 1,3-dithiolan, 1,3-dithian, acrylamide, pyrazole, pyrazolopyrimidine and benzochromene moieties, Chem. Pharm. Bull.60 (2012) 1019–1028; DOI: org/10.-1248/cpb.c12-00292.]Search in Google Scholar
[22. P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenney and M. R. Boyd, New colorimetric cytotoxicity assay for anticancer-drug screening, J. Natl. Cancer. Inst. 82 (1990) 1107–1112; DOI: 10.1093/jnci/-82.13.1107.]Search in Google Scholar
[23. M. M. Ghorab, M. S. Alsaid, H. A. Ghabour and H. K. Fun, Synthesis, crystal structure and anti-tumor activity of novel 2-cyano-N-(quinolin-3-yl) acetamide, Asian. J. Chem.26 (2014) 7389–7392; DOI: 10.14233/ajchem.17050.]Search in Google Scholar
[24. Y. Ogata and M. Tsuchida, Kinetics and mechanism of the Perkin reaction, J. Org. Chem.24 (1959) 78–83; DOI: 10.1021/jo01083a023.10.1021/jo01083a023]Search in Google Scholar